Solid Biosciences Inc. — Director's Dealing 2024

Jan 20, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-01-11

Reporting Person: BCLS II Equity Opportunities GP, LLC (N/A)
Reporting Person: BCLS II Equity Opportunities, LP (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	904160	Indirect

Footnotes

F1: Represents 904,160 shares of Common Stock purchased by BCLS II Equity Opportunities, LP ("BCLS II Equity") directly from the Issuer in a private placement that closed on January 11, 2024.

F2: BCLS II Equity Opportunities GP, LLC ("BCLS II Equity GP") is the general partner of BCLS II Equity. As a result, BCLS II Equity GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Equity. BCLS II Equity GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.